Executive Summary: Market for Generic Biologics: Issues, Trends, and Market Potential, 2nd editionKalorama Information Executive SummariesNovember 1, 2005 9 Pages - SKU: KLE1198635 |
|
China Pharmaceutical Mfg. Industry Profile - CIC27
5/31/2013 | published by: Beijing Zeefer Consulting Ltd.
China Pharmaceutical Mfg. Industry Profile - CIC27 Through a comparative analysis on the development of pharmaceutical mfg. industry in 31 provincial regions and 20 major cities in visualized form of data map, the report provides key
|
read more...
|
$580.00
|
|
Bangladesh Pharmaceuticals and Healthcare Report Q3 2013
5/29/2013 | published by: Business Monitor International
BMI View: While Bangladesh has a substantial population of 152mn people, annual per capita expenditureon healthcare is very modest at just US$28. Despite expected economic progress, the majority of thepopulation will continue to have inadequate
|
read more...
|
$1,295.00
|
|
South Korea Pharmaceutical Market Outlook 2013
5/14/2013 | published by: GBI Research
South Korea Pharmaceutical Market Outlook 2013 Summary GBI Research’s new report “South Korea Pharmaceutical Market Outlook 2013” provides in-depth analysis of the trends, issues and challenges facing the South Korean pharmaceutical market. The report also provides competitive
|
read more...
|
$3,500.00
|
|
Conference Documentation: Generics and Patent Strategies 2013
5/13/2013 | published by: SMI Publishing, Ltd
Join SMi for their 16th annual conference on Generics and Patent Strategies to be held in central London on 13th-14th May 2013. This event never fails to disappoint and will address the hottest topics and
|
read more...
|
$788.78
|
|
Post-Patent Generic and Biosimilar Defense Strategies
4/1/2013 | published by: Cutting Edge Information
Post-Patent Generic and Biosimilar Defense Strategies
Create Robust Counter-Generics Strategies to Maximize Market Share As Patents Expire
Fresh off of 2012’s patent cliff, the life sciences industry is bracing for a second
|
read more...
|
$7,695.00
|
|
Generic And Innovative Drugs Market In Central Europe 2013
5/1/2013 | published by: PMR
Compare generic & innovative drug markets across Central Europe.
Report studies reimbursement regulations; forecasts market growth for 2013-2015.
Generic and innovative medicines represent key advancements
|
read more...
|
$3,500.00
|
|
Generic Pharmaceutical Manufacturing in the US - Industry Risk Rating Report
4/24/2013 | published by: IBISWorld
Industry Risk Ratings Synopsis This Industry Risk Ratings report from IBISWorld evaluates the inherent risks associated with the Generic Pharmaceutical Manufacturing in the US industry. Industry Risk is assumed to be 'the difficulty, or otherwise, of
|
read more...
|
$1,020.00
|
|
The Politics of Pharma (CBRSV042) – Washington, States, and the Courts Impact on the Industry
4/1/2013 | published by: CBR Pharma Insights, LLC
Politics have a greater direct effect on the pharmaceutical industry than almost any other in the US, and correspondingly, pharma makes considerable investments in election campaigns. The November elections kept the face of Washington the
|
read more...
|
$3,900.00
|
|
Generic and innovative drugs market in CIS countries 2013. Russia, Ukraine and Kazakhstan
4/1/2013 | published by: PMR
Keep current with the changing CIS generic and innovative drug segments. Survey conditions and track market development in Russian Ukraine and Kazakhstan to 2015. Generic and innovative drug segments in CIS countries have played a huge role
|
read more...
|
$2,800.00
|
|
PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
3/31/2013 | published by: GlobalData
PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013 Summary PharmaLeaders: Generic Manufacturers Benchmark Report - Financial Benchmarking & Competitive Analysis of the Leading Generic Players in 2013
|
read more...
|
$3,995.00
|
Research assistance
We can help you find what you need. Call us or write us: Need help in your search?
US: 800.298.5699
Int'l: +1.240.747.3093
Related Markets
Generics Drugs Reports